Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) has accepted the ...
Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...
The once-large pool of candidates hoping to unseat U.S. House Rep. Lauren Boebert in the 3rd Congressional District was nearly halved this week after five Democratic candidates failed to qualify for ...
Last week, readers heard from the Democratic candidates for the Third Congressional District (CD3) race. Now, it’s time to hear from the Republican incumbent, Representative Lauren Boebert, and GOP ...
A short course of anti-CD3 antibody therapy decreases the insulin needs of patients with type 1 diabetes mellitus (T1DM) during the first few years after diagnosis, new data of a phase II trial reveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results